Tomasz Urasiński

881 total citations
8 papers, 78 citations indexed

About

Tomasz Urasiński is a scholar working on Genetics, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Tomasz Urasiński has authored 8 papers receiving a total of 78 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 3 papers in Public Health, Environmental and Occupational Health and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Tomasz Urasiński's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers), Acute Lymphoblastic Leukemia research (2 papers) and Acute Myeloid Leukemia Research (1 paper). Tomasz Urasiński is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers), Acute Lymphoblastic Leukemia research (2 papers) and Acute Myeloid Leukemia Research (1 paper). Tomasz Urasiński collaborates with scholars based in Poland. Tomasz Urasiński's co-authors include Andrzej Pogorzelski, Maria Olszewska, H. Bukowska, Jerzy Kowalczyk, Beata Burzyńska, Monika Góra, Katarzyna Derwich, Danuta Płochocka, Jarosław Poznański and Wanda Badowska and has published in prestigious journals such as Pediatric Nephrology, Blood Cells Molecules and Diseases and European journal of medical research.

In The Last Decade

Tomasz Urasiński

7 papers receiving 76 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomasz Urasiński Poland 5 35 24 16 13 11 8 78
Naomi Fearon Ireland 8 25 0.7× 10 0.4× 19 1.2× 2 0.2× 4 0.4× 19 105
Marianna Zsom United States 4 9 0.3× 45 1.9× 5 0.3× 6 0.5× 2 0.2× 4 79
James Johnstone United Kingdom 4 13 0.4× 13 0.5× 7 0.4× 2 0.2× 19 1.7× 8 106
O. Dupuy France 6 17 0.5× 11 0.5× 11 0.7× 6 0.5× 23 104
Alp Burak Çatakoğlu Türkiye 7 16 0.5× 7 0.3× 15 0.9× 3 0.2× 2 0.2× 14 112
Е. В. Колмакова Russia 3 10 0.3× 15 0.6× 4 0.3× 7 0.5× 4 0.4× 4 77
Julio Hernández Jaras Spain 4 6 0.2× 28 1.2× 9 0.6× 12 0.9× 1 0.1× 23 57
Adrián Alegre Amor Spain 4 4 0.1× 32 1.3× 4 0.3× 26 2.0× 2 0.2× 5 71
Guanqing Xiao China 6 4 0.1× 42 1.8× 11 0.7× 4 0.3× 3 0.3× 9 90
Amr Marawan United States 4 8 0.2× 15 0.6× 13 0.8× 3 0.2× 10 0.9× 5 156

Countries citing papers authored by Tomasz Urasiński

Since Specialization
Citations

This map shows the geographic impact of Tomasz Urasiński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomasz Urasiński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomasz Urasiński more than expected).

Fields of papers citing papers by Tomasz Urasiński

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomasz Urasiński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomasz Urasiński. The network helps show where Tomasz Urasiński may publish in the future.

Co-authorship network of co-authors of Tomasz Urasiński

This figure shows the co-authorship network connecting the top 25 collaborators of Tomasz Urasiński. A scholar is included among the top collaborators of Tomasz Urasiński based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomasz Urasiński. Tomasz Urasiński is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Sędek, Łukasz, Iwona Malinowska, Joanna Zawitkowska, et al.. (2022). Expression of CD73 on leukemic blasts increases during follow-up – a promising candidate marker for minimal residual disease detection in pediatric B-cell precursor acute lymphoblastic leukemia. Central European Journal of Immunology. 47(1). 84–91. 2 indexed citations
2.
Poznański, Jarosław, et al.. (2019). Hereditary xerocytosis - spectrum and clinical manifestations of variants in the PIEZO1 gene, including co-occurrence with a novel β-globin mutation. Blood Cells Molecules and Diseases. 80. 102378–102378. 6 indexed citations
3.
Styczyński, Jan, K Czyźewski, Mariusz Wysocki, et al.. (2014). Posaconazole in invasive fungal infections in children treated in Polish pediatric hemato-oncology or stem cell transplant units. Homo Politicus (Academy of Humanities and Economics in Lodz). 5(3). 151–155.
4.
Birkenfeld, Bożena, et al.. (2010). [The association between gastroesophageal reflux and recurrent lower respiratory tract infections and bronchial asthma in children].. PubMed. 56(3). 13–9. 3 indexed citations
5.
Urasiński, Tomasz, et al.. (2009). Idiopathic pulmonary hemosiderosis in a 9-year-old girl. European journal of medical research. 14(S4). 112–5. 22 indexed citations
6.
Styczyński, Jan, Lidia Gil, Katarzyna Derwich, et al.. (2009). Comparison of clofarabine activity in childhood and adult acute leukemia: individual tumor response study.. PubMed. 29(5). 1643–50. 7 indexed citations
7.
Olszewska, Maria, et al.. (2003). Serum selenium level and glutathione peroxidase activity in steroid-sensitive nephrotic syndrome. Pediatric Nephrology. 18(10). 1063–1065. 13 indexed citations
8.
Urasiński, Tomasz, et al.. (1998). Antioxidant status of children with steroid-sensitive nephrotic syndrome. Pediatric Nephrology. 12(9). 751–754. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026